Patent details

EP3703747 Title: USE OF A NOX4 OR NOX4/1 INHIBITOR IN COMBINATION WITH AN IMMUNOTHERAPEUTIC AGENT FOR THE TREATMENT OF CANCER

Basic Information

Publication number:
EP3703747
PCT Application Number:
EP2018079945
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP188008718
PCT Publication Number:
WO2019086579
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF A NOX4 OR NOX4/1 INHIBITOR IN COMBINATION WITH AN IMMUNOTHERAPEUTIC AGENT FOR THE TREATMENT OF CANCER
French Title of Invention:
UTILISATION D'UN INHIBITEUR DE NOX4 OU NOX4/1 EN COMBINAISON AVEC UN AGENT IMMUNOTHÉRAPEUTIQUE POUR LE TRAITEMENT DU CANCER
German Title of Invention:
VERWENDUNG EINES NOX4 ODER NOX4/1 INHIBITORS IN KOMBINATION MIT EINEM IMMUNTHERAPEUTISCHEN MITTEL ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
01/11/2018
Grant date:
03/09/2025
EP Publication Date:
09/09/2020
PCT Publication Date:
09/05/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/09/2025
EP B1 Publication Date:
03/09/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
01/11/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/08/2025
 
 

Name:
Calliditas Therapeutics Suisse SA
Address:
chemin des Aulx 14, 1228 Plan-les-Ouates, Switzerland (CH)

Name:
University Of Southampton
Address:
University Road, Southampton, Hampshire SO17 1BJ, United Kingdom (GB)

Inventor

1

Name:
HANLEY, Christopher
Address:
United Kingdom (GB)

2

Name:
FORD, Kirsty
Address:
United Kingdom (GB)

3

Name:
THOMAS, Gareth
Address:
United Kingdom (GB)

4

Name:
HEITZ, Freddy
Address:
Switzerland (CH)

5

Name:
WIESEL, Philippe
Address:
France (FR)

Priority

Priority Number:
17199601
Priority Date:
01/11/2017
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/437; A61K 39/395; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202536
Publication date:
03/09/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages